Literature DB >> 23764922

Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.

Katrin Weigmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23764922      PMCID： PMC3701248          DOI： 10.1038/embor.2013.82

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  10 in total

Review 1.  Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.

Authors:  Gaurvika M L Nayyar; Joel G Breman; Paul N Newton; James Herrington
Journal:  Lancet Infect Dis       Date:  2012-06       Impact factor: 25.071

2.  EU implicated in controversial counterfeiting bill.

Authors:  Asher Mullard
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

3.  Quality of amoxicillin formulations in some Arab countries.

Authors:  S Kyriacos; M Mroueh; R P Chahine; O Khouzam
Journal:  J Clin Pharm Ther       Date:  2008-08       Impact factor: 2.512

4.  Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies.

Authors:  Marc Twagirumukiza; An Cosijns; Eveline Pringels; Jean Paul Remon; Chris Vervaet; Luc Van Bortel
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

5.  How to achieve international action on falsified and substandard medicines.

Authors:  Amir Attaran; Donna Barry; Shamnad Basheer; Roger Bate; David Benton; James Chauvin; Laurie Garrett; Ilona Kickbusch; Jillian Clare Kohler; Kamal Midha; Paul N Newton; Sania Nishtar; Paul Orhii; Martin McKee
Journal:  BMJ       Date:  2012-11-13

6.  Impact of poor-quality medicines in the 'developing' world.

Authors:  Paul N Newton; Michael D Green; Facundo M Fernández
Journal:  Trends Pharmacol Sci       Date:  2010-02-01       Impact factor: 14.819

7.  Outbreak of acute renal failure in Panama in 2006: a case-control study.

Authors:  E Danielle Rentz; Lauren Lewis; Oscar J Mujica; Dana B Barr; Joshua G Schier; Gayanga Weerasekera; Peter Kuklenyik; Michael McGeehin; John Osterloh; Jacob Wamsley; Washington Lum; Camilo Alleyne; Nestor Sosa; Jorge Motta; Carol Rubin
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

8.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.

Authors:  Aung Pyae Phyo; Standwell Nkhoma; Kasia Stepniewska; Elizabeth A Ashley; Shalini Nair; Rose McGready; Carit ler Moo; Salma Al-Saai; Arjen M Dondorp; Khin Maung Lwin; Pratap Singhasivanon; Nicholas P J Day; Nicholas J White; Tim J C Anderson; François Nosten
Journal:  Lancet       Date:  2012-04-05       Impact factor: 79.321

Review 9.  Potential risks of pharmacy compounding.

Authors:  Jennifer Gudeman; Michael Jozwiakowski; John Chollet; Michael Randell
Journal:  Drugs R D       Date:  2013-03

10.  The global threat of counterfeit drugs: why industry and governments must communicate the dangers.

Authors:  Robert Cockburn; Paul N Newton; E Kyeremateng Agyarko; Dora Akunyili; Nicholas J White
Journal:  PLoS Med       Date:  2005-03-14       Impact factor: 11.069
  10 in total
  2 in total

1.  Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.

Authors:  Mathilda Tivura; Isaac Asante; Albert van Wyk; Stephaney Gyaase; Naiela Malik; Emmanuel Mahama; Dana M Hostetler; Facundo M Fernandez; Kwaku Poku Asante; Harparkash Kaur; Seth Owusu-Agyei
Journal:  BMC Pharmacol Toxicol       Date:  2016-10-28       Impact factor: 2.483

2.  Counterfeit medicines in Peru: a retrospective review (1997-2014).

Authors:  Edwin Medina; Elvira Bel; Josep María Suñé
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.